For the first time ever, BIO-Europe Spring 2026 will take place in Lisbon, Portugal, from 23 to 25 March, marking the 20th edition of this flagship event for the international biotechnology industry. The city’s vibrant life sciences ecosystem will welcome innovators, investors, and industry leaders to a week of networking, collaboration, and dealmaking.
Lisbon will become the epicentre of life science innovation this spring, as BIO-Europe Spring and LSX Europe converge for a landmark “Life Science Spring Innovation Week.” Participants will gain access to emerging Portuguese biotech companies, cutting-edge research, and global players shaping the future of healthcare. The LSX World Congress, held on 25–26 March, will complement the event by bringing together the Biotech, Medtech, and investor communities under one roof.
AICEP - Portugal’s Trade & Investment Agency, will play an active role, both through a stand at the FIL – Lisbon Exhibition Centre (23–25 March) and a networking event on 22 March at its Lisbon offices.
The Lisbon edition of BIO-Europe Spring will celebrate 20 years of international collaboration, innovation, and strategic partnerships, with an expected attendance of around 4,000 participants from over 50 countries. It offers an unparalleled platform for Portuguese companies and research centres to showcase their innovations to global investors and industry leaders.
Portugal combines world-class research institutions, high-performing biotech startups, strong public–private collaborations, and a highly qualified workforce. Key figures include:
- Exports to 184 markets, worth around €5.65 billion in 2025
- 4th worldwide in health researchers per million inhabitants
- Portugal has been recognised as one of the most innovative, business-friendly and stable countries. This favourable environment has enabled rapid e-Health growth, supported by a robust digital ecosystem.
- Portugal 10th | Digital Decade 2025: EU Digital Health Indicators Study.
- Dynamic startup scene supported by CoLabs and collaborative networks
By hosting BIO-Europe Spring 2026, Portugal reinforces its position as a credible, competitive, and innovative hub for life sciences investment, from developing novel therapies to sustainable biopharmaceutical production. Organised locally by Biocant Park, CoLab AccelBio and P-BIO, and supported by AICEP, this event underscores Portugal’s growing prominence in Europe’s biotech landscape.
Read more.
